Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,838 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single-cell immunoprofiling after immunotherapy for allergic rhinitis reveals functional suppression of pathogenic TH2 cells and clonal conversion.
Iinuma T, Kiuchi M, Hirahara K, Kurita J, Kokubo K, Yagyu H, Yoneda R, Arai T, Sonobe Y, Fukuyo M, Kaneda A, Yonekura S, Nakayama T, Okamoto Y, Hanazawa T. Iinuma T, et al. Among authors: okamoto y. J Allergy Clin Immunol. 2022 Oct;150(4):850-860.e5. doi: 10.1016/j.jaci.2022.06.024. Epub 2022 Jul 19. J Allergy Clin Immunol. 2022. PMID: 35863510 Free article.
[Pathophysiology of allergic rhinitis].
Konno A, Terada N, Nagata H, Sanai A, Ohkawa T, Hohki G, Okamoto Y. Konno A, et al. Among authors: okamoto y. Arerugi. 2002 Nov;51(11):1083-94. Arerugi. 2002. PMID: 12486334 Review. Japanese. No abstract available.
[Allergic rhinitis].
Okamoto Y. Okamoto Y. Nihon Rinsho. 2005 May;63 Suppl 5:96-101. Nihon Rinsho. 2005. PMID: 15954332 Review. Japanese. No abstract available.
A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer.
Motohashi S, Ishikawa A, Ishikawa E, Otsuji M, Iizasa T, Hanaoka H, Shimizu N, Horiguchi S, Okamoto Y, Fujii S, Taniguchi M, Fujisawa T, Nakayama T. Motohashi S, et al. Among authors: okamoto y. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6079-86. doi: 10.1158/1078-0432.CCR-06-0114. Epub 2006 Oct 6. Clin Cancer Res. 2006. PMID: 17028247 Clinical Trial.
Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer.
Uchida T, Horiguchi S, Tanaka Y, Yamamoto H, Kunii N, Motohashi S, Taniguchi M, Nakayama T, Okamoto Y. Uchida T, et al. Among authors: okamoto y. Cancer Immunol Immunother. 2008 Mar;57(3):337-45. doi: 10.1007/s00262-007-0373-5. Epub 2007 Aug 10. Cancer Immunol Immunother. 2008. PMID: 17690880 Free PMC article. Clinical Trial.
3,838 results